182
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Osteosarcoma in a Marfan patient with a novel premature termination codon in the FBN1 gene

, , , &
Pages 157-165 | Received 15 Feb 2010, Accepted 08 Jun 2010, Published online: 30 Jul 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Romy Franken, Thomas J Heesterbeek, Vivian de Waard, Aeilko H Zwinderman, Gerard Pals, Barbara JM Mulder & Maarten Groenink. (2014) Diagnosis and genetics of Marfan syndrome. Expert Opinion on Orphan Drugs 2:10, pages 1049-1062.
Read now

Articles from other publishers (4)

Kim M. Summers, Stephen J. Bush, Margaret R. Davis, David A. Hume, Sahar Keshvari & Jennifer A. West. (2023) Fibrillin-1 and asprosin, novel players in metabolic syndrome. Molecular Genetics and Metabolism 138:1, pages 106979.
Crossref
GUO-PING XIE, HUI-JUAN SONG, NAN JIANG, CHENG-HE QIN, LEI WANG, SHAO-YONG XU & BIN YU. (2016) Periosteal osteosarcoma and Marfan's syndrome: A case report and literature review. Oncology Letters 11:1, pages 311-315.
Crossref
Daniel A. Winer, Shawn Winer, Lorne Rotstein, Sylvia L. Asa & Ozgur Mete. (2012) Villous Papillary Thyroid Carcinoma: a Variant Associated with Marfan Syndrome. Endocrine Pathology 23:4, pages 254-259.
Crossref
. (2012) Current World Literature. Current Opinion in Pediatrics 24:4, pages 547-553.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.